Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

EXELIXIS, INC.

EXEL · Nasdaq · CIK 0000939767 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

28 Form 4 transaction lines observed in the same window
10 sales · 18 option, withholding, award, gift or other lines

Last qualifying purchase2025-11-25 · Caligan Partners LP; JOHNSON DAVID EDWARD · $1.2M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Beckerle Mary CDirector
○▼○▼
Freire Maria CDirector
○▼○
MORRISSEY MICHAELPresident and CEO
○○○
WYSZOMIERSKI JACK LDirector
○▼
Eckhardt Sue GailDirector
○▼
POSTE GEORGEDirector
▼○
● Purchase▼ Sale○ Other

Showing the six most active owners; 8 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-11-25 · Caligan Partners LP; JOHNSON DAVID EDWARD.

Recent Form 4 activity

1Purchases
32Sales
54Other Form 4 lines
52SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING10 sale line(s) · context only
OTHER18 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
28,183,726
Previous report
26,400,456
Avg daily volume
2,228,196
Days to cover
12.7

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-11-25Caligan Partners LP; JOHNSON DAVID EDWARDPurchase (P)Common Stock27,532USD 43.12USD 1,187,180SEC filing ↗
2024-05-30Caligan Partners LP; JOHNSON DAVID EDWARDPurchase (P)Common Stock225,000USD 20.76USD 4,671,000SEC filing ↗
2024-05-28Caligan Partners LP; JOHNSON DAVID EDWARDPurchase (P)Common Stock200,000USD 20.32USD 4,064,000SEC filing ↗
2024-02-21Caligan Partners LP; JOHNSON DAVID EDWARDPurchase (P)Common Stock190,000USD 20.70USD 3,933,000SEC filing ↗
2023-11-27Caligan Partners LP; JOHNSON DAVID EDWARDPurchase (P)Common Stock120,409USD 21.61USD 2,602,038SEC filing ↗

Form 4 evidence

87 transaction lines in the latest 365-day window; 824 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-10Beckerle Mary CSale (S)Common Stock9,812USD 53.66USD 526,512SEC filing ↗
2026-06-01WYSZOMIERSKI JACK LSale (S)Common Stock3,925USD 50.55USD 198,409SEC filing ↗
2026-06-01Eckhardt Sue GailSale (S)Common Stock9,812USD 50.14USD 491,974SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-10Beckerle Mary CSale (S)Common Stock9,812USD 53.66USD 526,512SEC filing ↗
2026-06-01WYSZOMIERSKI JACK LSale (S)Common Stock3,925USD 50.55USD 198,409SEC filing ↗
2026-06-01Eckhardt Sue GailSale (S)Common Stock9,812USD 50.14USD 491,974SEC filing ↗
2026-05-27WYSZOMIERSKI JACK LAward / grant (A)Common Stock8,367USD 0.00USD 0SEC filing ↗
2026-05-27Smith JulieAward / grant (A)Common Stock8,367USD 0.00USD 0SEC filing ↗
2026-05-27POSTE GEORGEAward / grant (A)Common Stock8,367USD 0.00USD 0SEC filing ↗
2026-05-27PAPADOPOULOS STELIOSAward / grant (A)Common Stock8,367USD 0.00USD 0SEC filing ↗
2026-05-27Oliver BobAward / grant (A)Common Stock8,367USD 0.00USD 0SEC filing ↗
2026-05-27Heyman Tomas J.Award / grant (A)Common Stock8,367USD 0.00USD 0SEC filing ↗
2026-05-27Freire Maria CAward / grant (A)Common Stock8,367USD 0.00USD 0SEC filing ↗
2026-05-27Eckhardt Sue GailAward / grant (A)Common Stock8,367USD 0.00USD 0SEC filing ↗
2026-05-27Beckerle Mary CAward / grant (A)Common Stock8,367USD 0.00USD 0SEC filing ↗
2026-05-26Aftab DanaSale (S)Common Stock43,451USD 50.35USD 2,187,758SEC filing ↗
2026-05-20Haley Patrick J.Sale (S)Common Stock32,110USD 49.81USD 1,599,399SEC filing ↗
2026-05-18Senner Christopher J.Sale (S)Common Stock34,901USD 50.00USD 1,745,050SEC filing ↗
2026-05-18MORRISSEY MICHAELGift (G)Common Stock124,047USD 0.00USD 0SEC filing ↗
2026-05-18Hefti BrendaSale (S)Common Stock6,625USD 50.21USD 332,641SEC filing ↗
2026-05-15Senner Christopher J.Tax withholding (F)Common Stock40,892USD 51.10USD 2,089,581SEC filing ↗
2026-05-15MORRISSEY MICHAELTax withholding (F)Common Stock128,497USD 51.10USD 6,566,197SEC filing ↗
2026-05-15Hefti BrendaTax withholding (F)Common Stock6,411USD 51.10USD 327,602SEC filing ↗
2026-05-15Haley Patrick J.Tax withholding (F)Common Stock33,265USD 51.10USD 1,699,842SEC filing ↗
2026-05-15Aftab DanaTax withholding (F)Common Stock30,578USD 51.10USD 1,562,536SEC filing ↗
2026-05-07POSTE GEORGESale (S)Common Stock60,000USD 45.71USD 2,742,600SEC filing ↗
2026-05-07Freire Maria CSale (S)Common Stock20,634USD 46.00USD 949,164SEC filing ↗
2026-05-07Freire Maria COption exercise / conversion (M)Common Stock20,634USD 19.77USD 407,934SEC filing ↗
2026-05-07Beckerle Mary CSale (S)Common Stock7,712USD 48.45USD 373,646SEC filing ↗
2026-05-07Beckerle Mary COption exercise / conversion (M)Common Stock3,856USD 23.24USD 89,613SEC filing ↗
2026-05-06MORRISSEY MICHAELGift (G)Common Stock109,676USD 0.00USD 0SEC filing ↗
2026-02-26Senner Christopher J.Award / grant (A)Common Stock52,018USD 0.00USD 0SEC filing ↗
2026-02-26MORRISSEY MICHAELAward / grant (A)Common Stock160,437USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerEXEL
CIK0000939767
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history824 transaction lines from 2020-01-02 to 2026-08-10
5 P purchase lines · 235 S sale lines · 584 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.